AU2001295885A1 - Cosmetic formulation - Google Patents

Cosmetic formulation

Info

Publication number
AU2001295885A1
AU2001295885A1 AU2001295885A AU9588501A AU2001295885A1 AU 2001295885 A1 AU2001295885 A1 AU 2001295885A1 AU 2001295885 A AU2001295885 A AU 2001295885A AU 9588501 A AU9588501 A AU 9588501A AU 2001295885 A1 AU2001295885 A1 AU 2001295885A1
Authority
AU
Australia
Prior art keywords
sebum
active principles
skin
total weight
topical use
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001295885A
Inventor
Siro Passi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PROVINCIA ITALIANA DELLA CONGREGAZIONE DEI FIGLI DELL'IMMACOLATA CONCEZIONE - ISTITUTO DERMOPATICO DELL'IMMACOLATA
Original Assignee
IDI IRCCS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IDI IRCCS filed Critical IDI IRCCS
Publication of AU2001295885A1 publication Critical patent/AU2001295885A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/602Glycosides, e.g. rutin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35Ketones, e.g. benzophenone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/447Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof containing sulfur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63Steroids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/676Ascorbic acid, i.e. vitamin C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/678Tocopherol, i.e. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9771Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/522Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Cosmetics (AREA)

Description

Cosmetic formulation
The present invention relates to cosmetics and more particularly cosmetic formulations for topical administering to protect skin against exogenous or endogenous harmful agents as well as to balance again the dermal homeostasis lipids altered by dermatosis and ageing. Such formulations include active principles of strictly natural origin, all of them fulfilling the following requirements: a) having a lipid composition which is close to the human sebum; b) having a pool of antioxidants similar to those present in sebum and skin; c) having anti-inflammatory and anti-free-radical molecules also capable of preventing histidine from being decarboxylated and then histamine to be formed.
The rational principle of the present invention is to formulate and to prepare topical products of strictly natural origin which are capable of reproducing the human sebum so as to carry the active principles contained therein without the skin gives rise to self- defence systems against exogenous products by the contact with the carrier.
Another object of the invention is to provide anallergenic cosmetic formulations which are unable to induce dermal allergic contact reactions.
In order to achieve such result, according to the invention, it is necessary to provide formulations containing active principles of strictly natural origin which fulfil three .main requirements: a) having a lipid composition which is as close as possible to the human sebum; b) having a pool of antioxidants similar to those present in sebum and skin; c) having anti- inflammatory and anti-free-radical molecules also capable of preventing histidine from being decarboxylated and then histamine to be formed. The whole knowledge about chemistry and biology of dermal lipids brought to formulate a mixture of lipids similar to sebum of strictly natural origin in a previous Patent application of the same Applicant which is integral with the present description. Such formulation is close to the lipid composition of human sebum produced by oil glands.
A preferred formulation of such mixture (which will be referred to thereafter as oil A*) is as follows:
% Macadamia oil 50 Jojoba oil (wax) 24.5
Avocado oil 10
Unsaponifiable olive oil (squalene) 12 Free cholesterol 1.5
Oily cholesterol 0.5 Soya phospholipids 1.4
BHT (butylhydroxytoluene) 0.1
Therefore, a preparation having such formulation can provide a lipid component which is quite similar to the component present in the human sebum both from the quantitative and qualitative points of view according to above item a) . As far as item b) is concerned, i.e. the presence of antioxidants similar to those contained in human sebum and skin, the inventor has found recently, according to the researches carried out, that human sebum contains two main antioxidants, i.e. vitamin E (d-RRR- α-tocopherol) and ubiquinone (CoQ10) , which operate in syntony and synergy to protect sebum and particularly the polyunsaturated hydrocarbon squalene from the oxidation induced by solar radiations and other oxidizing agents present in the environment. Therefore, vitamin E (0.5-1.5%) and ubiquinone (0.02- 0.2%) together with magnesium ascorbyl phosphate or ascorbyl dipalmitate, a steady form of vitamin C (1- 3%) the hydrolysis of which generates vitamin C, can be used as main natural physiological antioxidants in the formulations according to the present invention. In some cases, extremely active flavonoids such as rutin and those present in association with ginkgoales in ginkgo biloba can also be used. The further characterizing component of the formulations of the present patent application is the presence of anti-inflammatory and anti-free-radical agents as well as inhibitors of the histidine decarboxylatio . It is known that histamine is formed from the decarboxylation of histidine, a molecule directly involved in the allergic reactions.
The invention proposes magnesium lactate (0.2-0.8%) and glycol salicylate (0.5-2.0%) to be used as inhibitors' of the histidine decarboxylation. Glycol salicylate is also known in the literature as dermal "counterirritant and anti-inflammatory" .
The antihistaminic action of such molecules was proved experimentally to be synergical with the above- mentioned antioxidants and anti-inflammatory agents such as α-bisabolol (0.2-0.8%) incorporated in its natural matrix, i.e. the extract of chamomile (0.1- 0.3%), glycyrrhetinic acid or its esters (0.2-1.0%), rutin (0.05-0.3%), the extract of ginkgo biloba (0.05- 0.3%), and aloe gel (0.1-0.6%) which is rich in polysaccharides .
A further characteristic of the invention is to provide in some case the use of benzophenone-3 , a known solar filter, whose anti-UV-A and anti-UV-B activity is associated with the anti-UV-B activity of glycol salicylate.
According to such teachings, some preferred formulations of nutrient anti-wrinkle oils and creams, beauty creams, anti-cellulitis creams, and cleansing milks within the scope of the present invention will be given herebelow only by way of a not limiting example .
Both the preferred proportion and the proportion range allowing the purposes of the present invention to be reached are mentioned for each component in the formulations of the following examples.
EXAMPLE 1 NUTRIENT ANTI-WRINKLE OILS
Ingredients (g, ml) range %
ACTIVE PRINCIPLES Sebum-similar oil (A*) 95 93-97 Ubiquinone 0.1 0.02-0.2
Natural vitamin E acetate 1.0 0.5-2.0 Ascorbyl palmitate 0.2 α-Bisabolol 0.2 0.1-0.5 Oily extract of chamomile 0.9 0.5-3 EXCIPIENT Soya phospholipids 2.3 1.5-4 Sepicide HB 0.4 0.4 SCENT Light perfume or others 0.1 0.05-0.3 EXAMPLE 2 NATURAL NUTRIENT SEBUM-SIMILAR CREAM
Ingredients (g, ml) % range
ACTIVE PRINCIPLES Sebum-similar oil (A*) 35 30-40
Ubiquinone 0.1 0.02-0.2
Natural vitamin E acetate 1.0 0.5-1.5
Glycol salicylate 1.0 0.5-1.5 α-Bisabolol 0.3 0.2-0.6 Extract of chamomile 0.1 0.1-0.3
Glycyrrhetinic acid or its esters 0.4 0.2-1
EXCIPIENT
Soya phospholipids 2.0 1.0-4
Glycerol 2.0 1.0-4 BHT (butylhydroxytoluene) 0.1
Tegin M (glycerol monostearate) 2.5
Tegocare 150 10.0*
Sepicide HB 0.4
Imidazolynidyl urea (IMU) 0.2 Bisodium EDTA 0.1
Water q.s. to 100
Scent 0.1 0.05-0.3
It should be noted that Tegin M, Tegocare 150 and
Sepicide HB can be replaced with Microcombin (0.5%), Tegin M (3.8%), Brij 721 (2.0%), Brij 58 (3.0%), and stearic alcohol (2.5%).
EXAMPLE 3 IMMUGEN CREAM
Ingredients (g, ml) % ranσe % ACTIVE PRINCIPLES
Sebum-similar oil (A*) 10 6-12
Ubiquinone 0.05 0.05-0.15
Vitamin E acetate 1.0 0.5-1.5
Ascorbyl palmitate 1.5 1-3 α-Bisabolol 0.3 0.2-0.5 Extract of chamomile 0.1 0..1-0.3
Glycol salicylate 1.0 0. .5-2
Magnesium lactate 0.3 0. .2-0.4
1-metionine 0.02 0. .01-0.03 Benzophenone-3 2.0 1- -3
EXCIPIENT
Silicone oil 350 1.0
Stearyl alcohol 1.0
Xanthan gum 0.2 Simulsol 165 V 1.0
BHT 0.1
Bisodium EDTA 0.2
Sepicide HB 0.4
Imidazolynidyl urea (IMU) 0.2 Brij 721 2.0
Brij 72 3.0
Water q.s. to 100
Scent 0.05 0 .005-0.3
Carbopol (0.3-0.4%) neutralized with NaOH (0.13-0.15%) can also be used as thickener. In any case, the excipients may vary. pH 6 : adjusting with EDTA or lactic acid
Papaya extract 1-2%
(for foreign creams)
BEAUTY CREAMS EXAMPLE 4 EXAMPLE 5 EXAMPLE 6
Carbopol (0.3*0.4%) neutralized with NaOH (0.13*0.15% can also be used as thickener. In any case the excipients may vary. pH 6: adjusting with EDTA or lactic acid. (*) Papaya extract (for foreign creams) 1-2% CLEANSING MILK
Sodium carbonate or NaOH to increase pH to 6 Papaya extract (for foreign creams)
MOISTURIZING CREAM
Carbopol (0.3*0.4%) neutralized with NaOH (0.13-^0.15%) can also be used as thickener. In any case the excipients may vary. pH 6: adjusting with EDTA or lactic acid.
Papaya extract (for foreign creams) 1-2% It is self-evident from the examples disclosed above that a number of modi ications and changes may be made to the formulations as far as the active principles is concerned without departing from the scope of the invention. Therefore, such modifications and changes, including the variations of nature and composition of the excipients, fall within the scope of the following claims which are intended to cover the general, specific features of the invention.

Claims (14)

Claims
1. A cosmetic formulation for topical use, including a mixture of active principles of natural origin fulfilling the following requirements: having a lipid composition close to the human sebum; having a pool of antioxidants similar to those present in sebum and skin; having anti-inflammatory and anti-free-radical molecules also capable of preventing histidine from being decarboxylated and then histamine to be formed.
2. The cosmetic formulation of claim 1, including: a mixture of macadamia oil and avocado oil in the same proportion as triglycerides in sebum; unsaponifiable olive oil in a proportion corresponding to squalene in sebum; jojoba wax in a proportion corresponding to waxes in sebum; free, esterified cholesterol in the same quantities as those in human sebum; a quantity of vitamin E (s-RRR-α-tocopherol) and ubiquinone as physiological antioxidants to protect sebum from oxidation induced by solar radiation and other oxidizing agents in the environment; an effective quantity of magnesium lactate and glycol salicylate as inhibitor of the histidine decarboxylation.
3. The cosmetic formulation of the preceding claims, characterized in that vitamin E and ubiquinone are used in association with effective quantities of ascorbyl dipalmitate, a steady form of vitamin C, or magnesium ascorbyl phosphate.
4. The cosmetic formulation of the preceding claims, further including an effective quantity of active flavonoids such as rutin and ginkgoales of ginkgo biloba as antioxidants.
5. The cosmetic formulation of the preceding claims, further including an effective quantity of α-bisabolol in its natural matrix and glycyrrhetinic acid or its esters to provide a synergic antihistaminic effect of magnesium lactate and glycol salicylate.
6. The cosmetic formulation of the preceding claims, further including benzophenone-3, whose anti-UV-A and anti-UV-B activity is associated with the anti-UV-B activity of glycol salicylate.
7. A nutrient, anti-wrinkle oil for topical use on skin, including the following active principles in weight percentages of the total weight of the product : Sebum-similar oil (A*) of the known type 93-97% Ubiquinone 0.02-0.2%
Natural vitamin E acetate 0.5-2.0%
Ascorbyl palmitate about 0.2% α-Bisabolol 0.1-0.5%
Oily extract of chamomile 0.5-3%
8. A natural nutrient, sebum-similar cream for topical use on skin, including the following active principles in weight percentages of the total weight of the product : Sebum-similar oil (A*) of the known type 30-40%
Ubiquinone 0.02-0.2%
Natural vitamin E acetate 0.5-1.5%
Glycol salicylate 0.5-1,5% α-Bisabolol 0.2-0.6% Extract of chamomile 0.1-0.3% Glycyrrhetinic acid or its esters 0.2-1%
9. A protective cream for topical use on skin, including the following active principles in weight percentages of the total weight of the composition: Sebum-similar oil (A*) of the known type 6-12
Ubiquinone 0.05-0.15
Vitamin E acetate 0.5-1.5
Ascorbyl palmitate 1-3
Glycol salicylate 0.5-2
Magnesium lactate 0.2-0.4 α-Bisabolol 0.2-0.5
Extract of chamomile 0.1-0.3
1-metionine 0.01-0.03
Benzophenone-3 1-3
10. Nutrient beauty cream for topical use on young skins, including the following active principles in weight percentage of the total weight of the composition:
11. A beauty cream for topical use for the prevention of skin ageing, including the following active principles in weight percentage of the total weight of the composition:
12. An anti-wrinkle beauty cream for the topical treatment of the skin ageing, including the following active principles in weight percentage of the total weight of the composition:
13. A cleansing milk for topical use on skin, including the following active principles in weight percentage of the total weight of the composition:
14. A hydrating milk for topical use on skin, including the following active principles in weight percentage of the total weight of the composition:
AU2001295885A 2000-09-28 2001-09-27 Cosmetic formulation Abandoned AU2001295885A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT2000RM000520A IT1317911B1 (en) 2000-09-28 2000-09-28 COSMETIC FORMULATION.
ITRM2000A000520 2000-09-28
PCT/IT2001/000495 WO2002026207A2 (en) 2000-09-28 2001-09-27 Cosmetic formulation

Publications (1)

Publication Number Publication Date
AU2001295885A1 true AU2001295885A1 (en) 2002-04-08

Family

ID=11454933

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001295885A Abandoned AU2001295885A1 (en) 2000-09-28 2001-09-27 Cosmetic formulation

Country Status (7)

Country Link
US (1) US20040013618A1 (en)
EP (1) EP1322285A2 (en)
JP (1) JP2004509913A (en)
AU (1) AU2001295885A1 (en)
CA (1) CA2423713A1 (en)
IT (1) IT1317911B1 (en)
WO (1) WO2002026207A2 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2831442B1 (en) * 2001-10-30 2005-02-11 Oreal COSMETIC COMPOSITION MIMING THE SEBUM, AND USES THEREOF
JP2004075549A (en) * 2002-08-12 2004-03-11 Kanebo Ltd Cosmetic
JP2004224742A (en) * 2003-01-23 2004-08-12 Umeken:Kk Skin care preparation
ITRM20030204A1 (en) * 2003-04-29 2004-10-30 Provincia Italiana Della Congregazi One Dei Figli DERMATOLOGICAL FORMULATION.
JP2005053842A (en) * 2003-08-05 2005-03-03 Asahi Kasei Chemicals Corp Skin cosmetic
DE102004008440A1 (en) * 2004-02-19 2005-09-22 Stockhausen Gmbh Cosmetic and / or dermatological agent for increasing the endogenous lipid content of the skin
JP2006056804A (en) * 2004-08-18 2006-03-02 Kanae Technos:Kk Sheet for face pack
CA2588131C (en) * 2004-12-22 2014-02-11 Avon Products, Inc. Method and composition for reducing the appearance of wrinkles
US7932417B2 (en) * 2006-05-19 2011-04-26 Mary Kay Inc. Glyceryl and glycol acid compounds
ITRM20060557A1 (en) * 2006-10-16 2008-04-17 Opocrin Spa PREPARATION FOR PALPEBRYAL AND PERIOCULAR HYGIENE WITH HIGH EYE AND SKIN TOLERABILITY
KR100823533B1 (en) * 2007-02-27 2008-04-30 바이오스펙트럼 주식회사 COMPOSITIONS FOR IMPROVING SKIN CONDITIONS COMPRISING alpha;-BISABOLOL AS AN ACTIVE INGREDIENT
JP5279539B2 (en) * 2009-02-06 2013-09-04 公益社団法人日本アロマ環境協会 Collagen production promoter, cosmetics, collagen production promotion method
FR2949044B1 (en) 2009-08-12 2021-05-07 Expanscience Lab COMPOSITION INCLUDING A FRACTION OF THE UNSAPONIFIABLE
US8343468B2 (en) * 2009-10-26 2013-01-01 International Flora Technologies, Ltd. Human sebum mimetics derived from botanical sources and methods for making the same
JP2012158554A (en) * 2011-02-01 2012-08-23 Mikimoto Pharmaceut Co Ltd Skin care preparation
ITMI20110507A1 (en) * 2011-03-29 2012-09-30 Biophil Italia Spa COMPOSITION FOR COSMETIC USE BASED ON TRIGLYCERIDES OF VEGETABLE ORIGIN
DE102011087320A1 (en) * 2011-11-29 2013-05-29 Henkel Ag & Co. Kgaa Novel combination of active ingredients for efficient anti-wrinkle action
WO2014041528A2 (en) * 2012-09-14 2014-03-20 Martin Roslain Margaret A composition
US20160009755A1 (en) * 2013-03-01 2016-01-14 Revlon Consumer Products Corporation Cyrrhetinic alkyl esters and protected derivatives thereof
KR102158895B1 (en) 2013-03-12 2020-09-22 마리 케이 인코포레이티드 Preservative system
KR102343454B1 (en) * 2013-09-30 2021-12-27 에이에이케이 아베 (파블) enrichment of triterpene esters
CA2932042C (en) * 2013-12-18 2020-06-02 International Flora Technologies, Ltd. Human sebum mimetics derived from botanical sources and methods for making the same
CA3026108A1 (en) 2016-06-10 2017-12-14 Clarity Cosmetics Inc. Non-comedogenic hair and scalp care formulations and method for use
JP6572337B2 (en) * 2018-02-28 2019-09-04 株式会社ファンケル Composition for promoting myokine production
WO2019212379A1 (en) * 2018-05-04 2019-11-07 Farber Boris Slavinovich Food, cosmetic and pharmaceutical formulation with an immunomodulatory and protective anti-viral effect
EP4110066A4 (en) * 2020-02-28 2024-04-17 Joyce H. Ma Formulations and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4022644A1 (en) * 1990-07-17 1992-01-23 Beiersdorf Ag SKIN CARE COMBINATIONS
US5215759A (en) * 1991-10-01 1993-06-01 Chanel, Inc. Cosmetic composition
US5494657A (en) * 1992-04-30 1996-02-27 Swenson; Russell H. Skin care formulation
GB9214634D0 (en) * 1992-07-09 1992-08-19 Lalvani Kartar S A cosmetic or pharmaceutical preparation
DE69526488T2 (en) * 1995-02-02 2002-08-14 Societe Des Produits Nestle S.A., Vevey Composition of oils for cosmetic products
DE19713092A1 (en) * 1997-03-27 1998-10-01 Wacker Chemie Gmbh Complexes of gamma-cyclodextrin and retinol or retinol derivatives, as well as processes for their preparation and their use
EP0875232B1 (en) * 1997-05-02 2002-02-13 Takasago International Corporation A lipid composition containing liquid crystal phase

Also Published As

Publication number Publication date
IT1317911B1 (en) 2003-07-15
EP1322285A2 (en) 2003-07-02
CA2423713A1 (en) 2002-04-04
WO2002026207A2 (en) 2002-04-04
JP2004509913A (en) 2004-04-02
ITRM20000520A1 (en) 2002-03-28
US20040013618A1 (en) 2004-01-22
ITRM20000520A0 (en) 2000-09-28
WO2002026207A3 (en) 2002-09-19

Similar Documents

Publication Publication Date Title
AU2001295885A1 (en) Cosmetic formulation
EP1002526B1 (en) Skin whitening composition containing bearberry extract and a reducing agent
AU735957B2 (en) Cosmetic and/or dermatological composition containing a derivative of methylated silanol and a derivative of hydrolysed plant protein
US20130195925A1 (en) Anti aging application and method for treating aging
US5436230A (en) Use of a growth factor in a slimming composition
CA2408575A1 (en) Cosmetic and/or dermatological composition based on cocoa extracts
EP0970691B1 (en) Composition for topical application containing a lipase, vitamin precursor and a fatty alcohol
JP2552297B2 (en) Beautiful skin cosmetics
CN116472023A (en) Deuterated polyunsaturated fatty acids or esters thereof for cosmetic applications
JP2007332066A (en) Tyrosinase production inhibitor
FR2687913A1 (en) COMPOSITION FOR TOPICAL TREATMENT CONTAINING LIPID VESICLES ENCAPSULATING AT LEAST MINERAL WATER.
CA2357961A1 (en) Method for reduction of inflammation and erythema
JP2003306419A (en) Cosmetic
JP2552298B2 (en) Beautiful skin cosmetics
JP3434911B2 (en) External preparation for skin
JP2009269851A (en) Inhibitor of prostaglandin e2 production and its utilization
JP6175280B2 (en) Composition for improving pores
JPH0118044B2 (en)
JP2000143485A (en) Composition for controlling aging of dermal cell
JPH111422A (en) Cosmetics
RU2259814C2 (en) Skin cream
RO108642B1 (en) Day cream for oily skin
JPH11322628A (en) External preparation for skin
JP2009137879A (en) Skin-whitening agent and skin-whitening cosmetic containing the same
JP2005035925A (en) External preparation for skin containing herbal medicine extract

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application